Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $285.94 -2.22%
EPS Growth %: -30.7%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.7%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.69, $0.50 better than the analyst estimate of $1.19. Revenue for the quarter came in at $510.4 million versus the consensus estimate of $526.16 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Sharon AI secures six-year compute deal with NVIDIA for Australia deployment
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
